Annual Drug Patent Expirations for NOREPINEPHRINE+BITARTRATE+IN+0.9%25+SODIUM+CHLORIDE
Norepinephrine Bitartrate In 0.9% Sodium Chloride is a drug marketed by Inforlife and Nevakar Injectables and is included in two NDAs. It is available from two suppliers. There are six patents protecting this drug.
This drug has three patent family members in two countries.
The generic ingredient in NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE is norepinephrine bitartrate. Two suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
